CitraNatal 90 DHA 300 mg DHA Soft Gel

Adult Female (18 - 50 Years) Lactating Pregnant Women NP NDC 0178-0821-30 Rx Only Please see the back for other important ingredients. 5-Day sample pack Sample - Not for sale Storage: Store at 20 degrees C to 25 degrees C (68 degrees F to 77 degrees F), excursions permitted between 15 degrees C and 30 degrees C (between 59 degrees F and 86 degrees F). Brief exposure to temperatures up to 40 degrees C (104 degrees F) may be tolerated provided the mean kinetic temperature does not exceed 25 degrees C (77 degrees F); however, such exposure should be minimized. Dosage and administration: One tablet and one soft gel daily or as directed by a physician.

Description: CitraNatal 90 DHA is a prescription prenatal/postnatal multi-vitamin/mineral tablet with Ferr-Ease, a patented dual-iron delivery comprising both a quick release and slow release iron, and a soft gel of DHA, an essential fatty acid. Life'sDHA CitraNatal Harmony, CitraNatal Assure, CitraNatal B-Calm, CitraNatal 90 DHA and CitraNatal Bloom contain Ferr-Ease. Quality ingredients, true comfort: 300 mg life'sDHA The essential fatty acid DHA soft gel is caramel colored and contains a light yellow to orange semi-solid mixture. Indications: CitraNatal 90 DHA ia a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mother. How Supplied: Six child-resistant blister packs of 5 tablets and 5 soft gels each Made in Canada Stool softener

Caution: Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 gram (1000 mg) per day. Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Please consult your health care provider with any dietary concerns. To report a serious adverse event or obtain product information, call (800) 298-1087 Warning: Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. In child-resistant packaging Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.